AFT Pharmaceuticals Limited (ASX:AFP)

Australia flag Australia · Delayed Price · Currency is AUD
3.190
+0.130 (4.25%)
At close: Dec 5, 2025
16.42%
Market Cap 342.03M
Revenue (ttm) 207.12M
Net Income (ttm) 15.30M
Shares Out n/a
EPS (ttm) 0.14
PE Ratio 22.36
Forward PE 23.67
Dividend 0.02 (0.55%)
Ex-Dividend Date Jun 18, 2025
Volume 1,100
Average Volume 3,771
Open 3.190
Previous Close 3.060
Day's Range 3.190 - 3.190
52-Week Range 2.200 - 3.300
Beta 0.45
RSI 65.42
Earnings Date Nov 19, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injecta... [Read more]

Sector Healthcare
Founded 1997
Employees 119
Stock Exchange Australian Securities Exchange
Ticker Symbol AFP
Full Company Profile

Financial Performance

In 2024, AFT Pharmaceuticals's revenue was 208.02 million, an increase of 6.45% compared to the previous year's 195.41 million. Earnings were 11.96 million, a decrease of -23.36%.

Financial numbers in NZD Financial Statements

News

AFT Pharmaceuticals Ltd (ASX:AFP) Half Year 2026 Earnings Call Highlights: Strong Sales Growth ...

AFT Pharmaceuticals Ltd (ASX:AFP) Half Year 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Expansion

15 days ago - GuruFocus

Half Year 2026 AFT Pharmaceuticals Ltd Earnings Call Transcript

Half Year 2026 AFT Pharmaceuticals Ltd Earnings Call Transcript

15 days ago - GuruFocus